Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.051 0.3
mRNA MS-275 GDSC1000 pan-cancer AAC 0.062 0.3
mRNA GW843682X CTRPv2 pan-cancer AAC 0.041 0.3
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.038 0.3
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.051 0.3
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.039 0.3
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.3
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.04 0.3
mRNA TG-100-115 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA lovastatin CTRPv2 pan-cancer AAC 0.043 0.3
Download CSV